United States · FDA National Drug Code directory

Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 61269-386_3e6cf4a3-11aa-4322-b507-8d3fff05c237
Product NDC: 61269-386
Form: CAPSULE
Composition / generic term: Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride
Labeler: H2-Pharma, LLC
Marketing category: NDA AUTHORIZED GENERIC
Marketing start / end (source format): 20250701
Source listing expiry: 20271231

Source-listed ingredients

BISMUTH SUBCITRATE POTASSIUM — 140 mg/1
METRONIDAZOLE — 125 mg/1
TETRACYCLINE HYDROCHLORIDE — 125 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

10 BLISTER PACK in 1 BOX (61269-386-12) / 12 CAPSULE in 1 BLISTER PACK · 61269-386-12

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →